Simcere Pharmaceutical Group Limited

HKEX:2096.HK

6.52 (HKD) • At close November 12, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12013 Q32013 Q22013 Q12012 Q42012 Q32012 Q22012 Q1
Revenue 1,556.7621,556.7621,614.2381,614.2381,689.6651,689.6651,812.2161,812.2161,349.8251,349.8251,439.8581,439.8581,060.0011,060.0011,291.6541,291.654962.707962.7071,311.3181,311.3181,207.0121,207.012421.301482.995528.729540.14504.715645.219600.82
Cost of Revenue 325.796325.796402.812402.812409.015409.015385.017385.017278.686278.686311.503311.503228.489228.489255.899255.899194.065194.065242.185242.185202.058202.058101.06881.54110.047101.93579.933103.867108.232
Gross Profit 1,230.9661,230.9661,211.4271,211.4271,280.651,280.651,427.21,427.21,071.141,071.141,128.3551,128.355831.513831.5131,035.7551,035.755768.642768.6421,069.1331,069.1331,004.9541,004.954320.233401.455418.682438.205424.782541.352492.588
Gross Profit Ratio 0.7910.7910.750.750.7580.7580.7880.7880.7940.7940.7840.7840.7840.7840.8020.8020.7980.7980.8150.8150.8330.8330.760.8310.7920.8110.8420.8390.82
Reseach & Development Expenses 283.065283.065402.667402.667387.946387.946545.866545.866325.769325.769403.668403.668313.402313.402352.633352.633227.046227.046239.729239.729126.266126.26647.5245.1544.9360.21664.67367.06359.497
General & Administrative Expenses 115.403115.403121.323121.323128.317128.317128.798128.79894.24194.241101.59101.5981.73981.739109.006109.00696.73296.73298.03998.03977.877.866.12865.31464.01274.38458.21768.0280.192
Selling & Marketing Expenses 577.81577.81554.542554.542623.651623.651686.715686.715514.668514.668603.264603.264415.089415.089470.936470.936314.251314.251489.677489.677518.434518.434206.766280.277259.557284.518300.208355.556318.877
SG&A 692.3692.3675.901675.901751.499751.499818.543818.543598.892598.892692.95692.95516.645516.645579.942579.942410.983410.983587.716587.716596.234596.234272.894345.591323.569358.902358.425423.576399.07
Other Expenses 9.5229.522932.96300000000000000000000000000
Operating Expenses 984.886984.8862,011.532,007.805124.449124.4491,017.191,017.191,050.7511,050.751696.787696.787560.902560.902726.2726.2621.912621.912782.643782.643709.92709.92220.555398.793379.188507.14400.546-494.082-437.458
Operating Income 246.08246.08-800.104175.991179.429179.429113.126113.126190.045190.04583.86683.86632.80132.801147.807147.807152.149152.149287.028287.028290.657290.657-0.18110.71450.183-21.3521.68450.71253.305
Operating Income Ratio 0.1580.158-0.4960.1090.1060.1060.0620.0620.1410.1410.0580.0580.0310.0310.1140.1140.1580.1580.2190.2190.2410.241-00.0220.095-0.040.0030.0790.089
Total Other Income Expenses Net 1.2671.2677.531-968.563983.163983.163303.74303.74-163.784-163.784356.113356.113228.119228.119142.371142.371-39.783-39.783-21.192-21.192-15.585-15.58594.581-18.022-22.922-60.2247.843-26.005-21.996
Income Before Tax 247.347247.347-792.573-792.5731,162.5921,162.592416.866416.86626.26226.262439.979439.979260.92260.92290.178290.178112.367112.367265.836265.836275.072275.07294.4-7.30827.261-81.5769.52724.70831.31
Income Before Tax Ratio 0.1590.159-0.491-0.4910.6880.6880.230.230.0190.0190.3060.3060.2460.2460.2250.2250.1170.1170.2030.2030.2280.2280.224-0.0150.052-0.1510.0190.0380.052
Income Tax Expense 19.04719.04712.62912.62925.67325.67315.5415.544.6994.69932.03532.03516.52816.52850.45250.45219.94919.9495.4735.47344.56844.5685.77610.316.50611.9193.2070.3123.249
Net Income 228.3228.3-779.944-779.9441,137.3241,137.324433.542433.54231.89231.892474.641474.641278.907278.907242.008242.00892.75992.759271.308271.308230.504230.504166.9598.22829.943-20.815.98932.91735.27
Net Income Ratio 0.1470.147-0.483-0.4830.6730.6730.2390.2390.0240.0240.330.330.2630.2630.1870.1870.0960.0960.2070.2070.1910.1910.3960.0170.057-0.0390.0320.0510.059
EPS 0.090.09-0.3-0.30.430.430.170.170.010.010.180.180.110.110.0990.0990.040.040.120.120.0980.0981.550.0780.28-0.20.150.310.32
EPS Diluted 0.090.09-0.3-0.30.430.430.170.170.0120.0120.180.180.110.110.0990.0990.040.040.120.120.0980.0981.550.0770.28-0.20.150.30.32
EBITDA 345.552345.552228.569228.569233.993233.993165.404165.404242.285242.285129.509129.50981.71881.718189.414189.414189.86189.86320.937320.937309.657309.65732.71543.6183.07911.54432.24788.00990.964
EBITDA Ratio 0.2220.2220.1420.1420.1380.1380.0910.0910.1790.1790.090.090.0770.0770.1470.1470.1970.1970.2450.2450.2570.2570.0780.090.1570.0210.0640.1360.151